Silo Pharma, Inc.
SILO
$1.06
-$0.0148-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -928.80K | -931.80K | -801.70K | -1.12M |
| Total Depreciation and Amortization | 3.10K | 3.10K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 0.00 | 1.30K | -200.00 | 67.00K |
| Change in Net Operating Assets | 810.10K | -420.80K | 198.70K | -36.30K | 144.20K |
| Cash from Operations | -917.40K | -1.35M | -731.80K | -838.20K | -910.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.70K | -40.40K | 954.30K | 97.60K | 4.43M |
| Cash from Investing | -37.70K | -40.40K | 954.30K | 97.60K | 4.43M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.74M | 1.67M | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | -57.70K | -115.50K | -194.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 1.74M | 1.62M | -115.50K | -194.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -955.10K | 354.60K | 1.84M | -856.00K | 3.32M |